2Heijtink RA, Kruining J, Honkoop P, et al. Serum HbeAg quanti- ration during antiviral therapy for chronic hepatitis BFJ]. J Med Virol, 1997,53 (3) : 282 - 287.
3骆抗先.乙型肝炎基础和临床[M]第2版[M].北京：人民卫生出版社,2001.43-70.
4Nahed Ismail,Geoffrey E, Fish,et al. Smith laboratory evaluation of a fully automated chemiluminescence immunoassay for rapid detection of HBsAg,antibodies to HBsAg,and antibodies to hepa- titis C virus[J]. J Clin Microbiol,2004,42(2) :610 - 617.
二级参考文献9
1Loeb KR, Jerome KR, Goddard J, et al. High-throughout quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system. Hepatology, 2000, 32: 626-629.
2Weinberger KM, Wiedenmann E, Bohm S, et al. Sensitive and accurate quantitation of hepatitis B virus DNA using a kinetic fluorescence detection system (TaqMan PCR). J Virol Methods, 2000, 85: 75-82.
3Pas SD, Fries E, DeMan RA, et al. Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays. J Clin Microbiol, 2000, 38: 2897-2901.
4Hunt CM, Mcgill JM, Allen MI, et al. Clinical relevance of hepatitis B viral mutations. Hepatology, 2000, 31: 1037-1044.
5Mason AL, Xu L, Guo L, et al. Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen. Hepatology, 1998, 27: 1736-1742.
6Kato J, Hasegawa K, Torii N, et al. A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B. Hepatology, 1996, 23: 389-395.
7Marusawa H, Uemoto S, Hijikoto M, et al. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology, 2000, 31: 488-495.
8Cabrerizo M, Bartolome J, Caramelo C, et al. Molecular analysis of hepatitis B virus DNA in serum and peripheral blood monnuclear cells from hepatitis B surface antigen-negative cases. Hepatology, 2000, 32: 116-123.
